Dalfampridine Unknown Status Phase 2 Trials for Episodic Ataxia Type 2 Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT015437504-Aminopyridine in Episodic Ataxia Type 2